Clinical contraindications to allergen immunotherapy: an EAACI position paper. - Wikidata - wikimedia - TriplyDB

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

http://www.wikidata.org/entity/Q34669524

about

Allergen immunotherapy in pregnancy Therapeutic interventions in severe asthma Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children The impact of national guidelines on venom immunotherapy practice in the United Kingdom.The relationship between autoimmunity and specific immunotherapy for allergic diseases.Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report Latest developments in allergic rhinitis in Allergy for clinicians and researchers.EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy.Allergic rhinitis: pharmacotherapy in pregnancy and old age.Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review.300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.IgE-associated allergic disorders: recent advances in etiology, diagnosis, and treatment.Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis.Asthma Outcomes and Management During Pregnancy.New trends in anaphylaxis.Chinese Guideline on allergen immunotherapy for allergic rhinitis.Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.Venom Immunotherapy in High-Risk Patients: The Advantage of the Rush Build-Up Protocol.Pediatric severe asthma: a case series report and perspectives on anti-IgE treatment.How to fit allergen immunotherapy in the elderly.A critical appraisal on AIT in childhood asthma.Immunotherapy and Asthma in Children

P2860

Q26777435-5C1414A5-6D99-4AAE-BDCF-FA130F65BD8C Q28079238-CA5B55C2-13CC-439B-A4AD-71678276A1CD Q33586188-FFE30135-E9FD-4DA5-B2D4-F02FBCABF0F7 Q36908101-169C7FC7-909F-44F6-87D5-E3DDD04349A6 Q37320206-61F6D6DC-27F8-4434-9E48-CC291CF0CBD6 Q37623049-2BFBA7E4-3776-4E9A-8C29-67B74082F1E7 Q37696401-56732B42-F569-4CB4-9AD4-E469953C65FC Q38600884-F2D447DC-D34E-48A5-A16B-3139435E1A1E Q38658310-780BE7AC-D4FA-4861-B12C-6FA7CF2511F5 Q38833851-A260355F-2FD5-44E0-ACA3-B065A59CBFCF Q38835526-C191E664-9820-46B9-AEFB-2D96A2CDFA42 Q38955332-FD01EBC8-3EF7-4A61-862D-59C6FE53218C Q38973411-0F6413D6-B8E5-4419-A132-082216F738C7 Q39037216-A9A7B93E-7F67-4975-8033-57A4165BED41 Q39399204-E5345C7F-675D-46C0-BBE6-B8144091A27D Q40059917-FCD179C4-7C5D-4BA4-9F8A-FBDC1B49D5C1 Q47117802-D2427E2A-67F8-41F1-B6F0-1D54D18DD205 Q47149942-EF291D4D-B5B8-4FB2-A09B-41F7FA63D282 Q47653403-553E09A6-A062-4B10-87BD-7C93FA2192CD Q47659621-12EB219E-3E3C-4C48-977A-3768570FD477 Q47690752-1558DA71-7BC1-4218-A2B6-6D2083286510 Q47764778-2D45259C-3548-42B8-B2B3-B488AACAF68E Q49821513-2C7EAE63-8EC7-419B-A1BA-EA6A4E3F50AD Q52691764-E2DDAA17-770E-4477-BE5C-C7F06DED12DD Q55280800-3B41E643-7AC7-4BA8-A31D-620AB008227A Q55334503-5EF61886-8C46-4F40-8BD5-8F23207D17BB Q58729387-5A7916A0-BF84-431A-8D2B-DE8089E14022

P2860

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

http://www.wikidata.org/entity/Q34669524

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@ast

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@en

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@nl

type

label

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@ast

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@en

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@nl

prefLabel

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@ast

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@en

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@nl

P1433

Q34669524-E80E2622-27D6-4443-BCCD-804CE8B407DB

P1476

Q34669524-CF5C8C77-6DEC-4264-AEF8-CDDF712E69D2

P2093

Q34669524-175833D9-0DBE-4425-8C11-818F343B40FE

Q34669524-19866E02-2573-4651-92E5-8E3046CB9B7F

Q34669524-61FAF1F4-80A0-436C-AF96-3E8AAC771343

Q34669524-6AA4D027-8972-4D99-938E-E8BF0D07A262

Q34669524-7E23B3DC-A830-4738-9B7A-A4056773FA78

Q34669524-973D18FB-E512-4053-8D3A-612BB2D0A5CC

Q34669524-B0DDCE31-52A6-4FF1-BA8F-A604750DA85D

Q34669524-B80BFA18-6807-4532-9548-1999FA2F861F

Q34669524-D1FB997D-8C47-42E7-9320-9CE0C3B58E9B

Q34669524-DDD47C8D-359A-4004-AF53-C5A2EB8D2DC6

P2860

Q34669524-0C2ECA8E-D75F-4AEC-851E-E6408885B990

Q34669524-0D968A25-B324-42FA-857E-5F6E6BE5DC24

Q34669524-11367FDB-60CA-41E6-A608-13E39AD98D8A

Q34669524-1278933C-3565-42FC-A1D1-75E2B7A1CA1A

Q34669524-1394C151-CDDD-4177-8206-2D4E5EECF2C8

Q34669524-155CE63A-EC03-442C-8888-DCC223501136

Q34669524-15F0C612-64A7-49A9-9CCA-E68D7E823A95

Q34669524-1EC1AB53-96B3-4082-A12F-058E59C8C81E

Q34669524-278D3651-D044-49DB-A2CD-545C2163B550

Q34669524-28C1365D-571A-4D4A-86A5-59C4D95452D2

P304

Q34669524-899CDCD6-FE3C-4C25-8BED-6C85A2911803

P31

Q34669524-5D5D9C23-44E4-4772-BE22-C1C2EAF3CBC3

P356

Q34669524-EC6BBAC5-140F-4E45-9CB2-DE59EE3C4DD3

P433

Q34669524-08A59C7F-C84D-487D-BFBE-2A2D8D088C16

P478

Q34669524-6142A8BC-6E00-4874-8759-B9FC00C09A50

P50

Q34669524-2BFDCD09-5A22-4F74-A14A-97C0E0080BDD

Q34669524-53C3B776-04FA-4569-941C-01AC446585F7

Q34669524-9D9E4BEB-87A2-442E-94A6-A4C416F6D93D

Q34669524-EFFEFFDD-759C-4618-8F4B-B31447CB9C89

P577

Q34669524-BCBEB7D0-1AC9-4AE6-8C67-455C046F6AD9

P5875

Q34669524-4B75A871-37A8-497E-ADA5-9CA0FFDE6366

P698

Q34669524-B6EFB9DA-B4CD-4A58-90A1-CE6A70D0F31E

P921

Q34669524-4CC75292-7E93-4713-8776-57C4F716B1C8

P356

P1433

P1476

Clinical contraindications to allergen immunotherapy: an EAACI position paper.

@en

P2093

E Valovirta

http://www.w3.org/2001/XMLSchema#string

F Ruëff

http://www.w3.org/2001/XMLSchema#string

G J Sturm

http://www.w3.org/2001/XMLSchema#string

G Paraskevopoulos

http://www.w3.org/2001/XMLSchema#string

M A Calderón

http://www.w3.org/2001/XMLSchema#string

M B Bilò

http://www.w3.org/2001/XMLSchema#string

M Tsoumani

http://www.w3.org/2001/XMLSchema#string

O Pfaar

http://www.w3.org/2001/XMLSchema#string

R Gawlik

http://www.w3.org/2001/XMLSchema#string

R Gerth van Wijk

http://www.w3.org/2001/XMLSchema#string

P2860

First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy

Monoamine Oxidase Inhibitors

International consensus on (ICON) pediatric asthma

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis.

Clinical guidelines: developing guidelines.

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.

Stinging insect hypersensitivity: a practice parameter update 2011.

Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.

Systemic reactions and fatalities associated with allergen immunotherapy.

P304

897-909

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.12638

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Pablo Rodríguez del Río

Nikolaos G Papadopoulos

P577

2015-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275525774

http://www.w3.org/2001/XMLSchema#string

P698

25913519

http://www.w3.org/2001/XMLSchema#string

P921